10/14/2013

Heart attack patients who were treated with the low-cost beta blocker metoprolol on their way to the hospital had 20% less heart tissue damage than those who received a placebo, according to a study in the journal Circulation. Patients with less heart tissue damage are less likely to require an implantable defibrillator and other expensive treatments or need long hospitalization, researchers said.

Full Story:
DailyRx.com

Related Summaries